Interference with the Host Haemostatic System by Schistosomes

PLoS Pathogens

Volumn 9, Issue 12, 2013, Pages 1-8

  Mebius, Mirjam M ^a   van Genderen, Perry J J ^b   Urbanus, Rolf T ^c   Tielens, Aloysius G M ^a   de Groot, Philip G ^c   van Hellemond, Jaap J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Harbour Hospital   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; ADENOSINE DIPHOSPHATE; ALKALINE PHOSPHATASE; ANNEXIN; ANTITHROMBIN; APYRASE; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 9A; BRADYKININ; ENOLASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN IB; HIGH MOLECULAR WEIGHT KININOGEN; KALLIKREIN; PLASMINOGEN; PROTEIN C; THROMBOXANE A2; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

BLOOD VESSEL TONE; ENZYME ACTIVITY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; NONHUMAN; ORGANISMAL INTERACTION; PATHOGENESIS; REGULATORY MECHANISM; REVIEW; SCHISTOSOMA; SCHISTOSOMIASIS; SURVIVAL; VASODILATATION; VIRULENCE; ANIMAL; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; HOST PARASITE INTERACTION; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; FIBRINOLYSIS; HEMOSTASIS; HOST-PARASITE INTERACTIONS; HUMANS; SCHISTOSOMA; SCHISTOSOMIASIS;

EID: 84892835723     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003781     Document Type: Review

References (77)

1. Klinger MH, Jelkmann W, (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22: 913-922.
2. Hoffbrand AV, Pettit JE, Moss PAH (2003) Essential haematology. Hoboken: Blackwell Science. 349 p.
3. Opal SM, (2003) Interactions between coagulation and inflammation. Scand J Infect Dis 35: 545-554.
4. Lowe GD, (2003) Virchow's triad revisited: Abnormal flow. Pathophysiol Haemost Thromb 33: 455-457.
5. Bagot CN, Arya R, (2008) Virchow and his triad: A question of attribution. Br J Haematol 143: 180-190.
6. Wolberg AS, Aleman MM, Leiderman K, Machlus KR, (2012) Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited. Anesth Analg 114: 275-285.
7. Gryseels B, Polman K, Clerinx J, Kestens L, (2006) Human schistosomiasis. Lancet 368: 1106-1118.
8. File S, (1995) Interaction of schistosome eggs with vascular endothelium. J Parasitol 81: 234-238.
9. Silva CL, Morel N, Noel F, (1998) Portal veins of mice infected with Schistosoma mansoni exhibit an increased reactivity to 5-hydroxytryptamine. Mem Inst Oswaldo Cruz 93 (Suppl 1) (): 153-155.
10. Colley DG, Secor WE, (2007) A schistosomiasis research agenda. PLoS Negl Trop Dis 1: e32 doi: 10.1371/journal.pntd.0000032.
11. Stein PD, Sabbah HN, (1974) Measured turbulence and its effect on thrombus formation. Circ Res 35: 608-614.
12. Johnson BD, Mather KJ, Wallace JP, (2011) Mechanotransduction of shear in the endothelium: Basic studies and clinical implications. Vasc Med 16: 365-377.
13. Diamond SL, Eskin SG, McIntire LV, (1989) Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 243: 1483-1485.
14. Galbusera M, Zoja C, Donadelli R, Paris S, Morigi M, et al. (1997) Fluid shear stress modulates von willebrand factor release from human vascular endothelium. Blood 90: 1558-1564.
15. Sun RJ, Muller S, Wang X, Zhuang FY, Stoltz JF, (2000) Regulation of von willebrand factor of human endothelial cells exposed to laminar flows: An in vitro study. Clin Hemorheol Microcirc 23: 1-11.
16. Mazzolai L, Silacci P, Bouzourene K, Daniel F, Brunner H, et al. (2002) Tissue factor activity is upregulated in human endothelial cells exposed to oscillatory shear stress. Thromb Haemost 87: 1062-1068.
17. Jin ZG, Ueba H, Tanimoto T, Lungu AO, Frame MD, et al. (2003) Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res 93: 354-363.
18. Walshe TE, Ferguson G, Connell P, O'Brien C, Cahill PA, (2005) Pulsatile flow increases the expression of eNOS, ET-1, and prostacyclin in a novel in vitro coculture model of the retinal vasculature. Invest Ophthalmol Vis Sci 46: 375-382.
19. Silva CL, Lenzi HL, Silva VF, Paulo FO, Noel F, (2003) Cellular mechanisms involved in the increased contraction of portal veins from Schistosoma mansoni-infected mice. Parasitol Res 89: 16-22.
20. Da'dara A, Skelly PJ, (2011) Manipulation of vascular function by blood flukes? Blood Rev 25: 175-179.
21. Oliveira SD, Quintas LE, Amaral LS, Noel F, Farsky SH, et al. (2011) Increased endothelial cell-leukocyte interaction in murine schistosomiasis: Possible priming of endothelial cells by the disease. PLoS One 6: e23547 doi: 10.1371/journal.pone.0023547.
22. Esterre P, Raobelison A, Ramarokoto CE, Ravaoalimalala VE, Boisier P, et al. (1998) Serum concentrations of sICAM-1, sE-, sP- and sL-selectins in patients with Schistosoma mansoni infection and association with disease severity. Parasite Immunol 20: 369-376.
23. Stein PC, Lumsden RD, (1973) Schistosoma mansoni: Topochemical features of cercariae, schistosomula, and adults. Exp Parasitol 33: 499-514.
24. Tanabe M, (2003) Haemostatic abnormalities in hepatosplenic schistosomiasis mansoni. Parasitol Int 52: 351-359.
25. Omran SA, el-Bassiouni NE, Hussein NA, Akl MM, Hussein AT, et al. (1995) Disseminated intravascular coagulation in endemic hepatosplenic schistosomiasis. Haemostasis 25: 218-228.
26. Carvalho MG, Mello RT, Soares AL, Bicalho RS, Lima e Silva FC, et al. (2005) Murine schistosomiasis mansoni: Process of blood coagulation at pre-patent, acute and chronic phases, and consequence of chemotherapeutic cure on the reversion of changes. Blood Coagul Fibrinolysis 16: 469-475.
27. Amin HM, Omran SA, el-Bassuoni NE, el-Kaliouby AH, el-Ashmawy SA, (1994) Assessment of factors II, VII, IX, X, and protein C in hepatosplenic schistosomiasis. Haemostasis 24: 22-26.
28. El-Bassiouni NE, El Bassiouny AE, Hussein NA, El-Sayed HH, Ibrahim IM, et al. (1998) The coagulation profile in hepatosplenic schistosomiasis. Blood Coagul Fibrinolysis 9: 189-194.
29. El-Bassiouni NE, el Bassiouny AE, el-Khayat HR, Akl MM, Omran SA, (1996) Hyperfibrinolysis in hepatosplenic schistosomiasis. J Clin Pathol 49: 990-993.
30. Wu YP, Lenting PJ, Tielens AGM, de Groot PG, van Hellemond JJ, (2007) Differential platelet adhesion to distinct life-cycle stages of the parasitic helminth Schistosoma mansoni. J Thromb Haemost 5: 2146-2148.
31. Sun H, (2006) The interaction between pathogens and the host coagulation system. Physiology (Bethesda) 21: 281-288.
32. Herrmann M, Hartleib J, Kehrel B, Montgomery RR, Sixma JJ, et al. (1997) Interaction of von willebrand factor with Staphylococcus aureus. J Infect Dis 176: 984-991.
33. Ngaiza JR, Doenhoff MJ, (1987) Schistosoma mansoni-induced thrombocytopenia in mice. Trans R Soc Trop Med Hyg 81: 655-656.
34. Correia MC, Domingues AL, Lacerda HR, Santos EM, Machado CG, et al. (2009) Platelet function and the von willebrand factor antigen in the hepatosplenic form of schistosomiasis mansoni. Trans R Soc Trop Med Hyg 103: 1053-1058.
35. Kaczmarek E, Koziak K, Sevigny J, Siegel JB, Anrather J, et al. (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271: 33116-33122.
36. Sevigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, et al. (2002) Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99: 2801-2809.
37. Born GV, (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927-929.
38. Born GV, Cross MJ, (1963) The aggregation of blood platelets. J Physiol 168: 178-195.
39. Bhardwaj R, Skelly PJ, (2009) Purinergic signaling and immune modulation at the schistosome surface? Trends Parasitol 25: 256-260.
40. Cesari IM, Simpson AJ, Evans WH, (1981) Properties of a series of tegumental membrane-bound phosphohydrolase activities of Schistosoma mansoni. Biochem J 198: 467-473.
41. Araujo-Montoya BO, Rofatto HK, Tararam CA, Farias LP, Oliveira KC, et al. (2011) Schistosoma mansoni: Molecular characterization of alkaline phosphatase and expression patterns across life cycle stages. Exp Parasitol 129: 284-291.
42. Millan JL, (2006) Alkaline phosphatases: Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes. Purinergic Signal 2: 335-341.
43. Bogitsh BJ, Krupa PL, (1971) Schistosoma mansoni and Haematoloechus medioplexus: Nuclosidediphosphatase localization in tegument. Exp Parasitol 30: 418-425.
44. Vasconcelos EG, Nascimento PS, Meirelles MN, Verjovski-Almeida S, Ferreira ST, (1993) Characterization and localization of an ATP-diphosphohydrolase on the external surface of the tegument of Schistosoma mansoni. Mol Biochem Parasitol 58: 205-214.
45. DeMarco R, Kowaltowski AT, Mortara RA, Verjovski-Almeida S, (2003) Molecular characterization and immunolocalization of Schistosoma mansoni ATP-diphosphohydrolase. Biochem Biophys Res Commun 307: 831-838.
46. Carvalho WS, Lopes CT, Juliano L, Coelho PM, Cunha-Melo JR, et al. (1998) Purification and partial characterization of kininogenase activity from Schistosoma mansoni adult worms. Parasitology 117: 311-319.
47. Cocude C, Pierrot C, Cetre C, Fontaine J, Godin C, et al. (1999) Identification of a developmentally regulated Schistosoma mansoni serine protease homologous to mouse plasma kallikrein and human factor I. Parasitology 118: 389-396.
48. Maurer M, Bader M, Bas M, Bossi F, Cicardi M, et al. (2011) New topics in bradykinin research. Allergy 66: 1397-1406.
49. Norris LA, (2003) Blood coagulation. Best Pract Res Clin Obstet Gynaecol 17: 369-383.
50. Nawroth PP, Stern DM, (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163: 740-745.
51. Wilner GD, Nossel HL, LeRoy EC, (1968) Activation of hageman factor by collagen. J Clin Invest 47: 2608-2615.
52. Espana F, Ratnoff OD, (1983) Activation of hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases. J Lab Clin Med 102: 31-45.
53. Renne T, Schmaier AH, Nickel KF, Blomback M, Maas C, (2012) In vivo roles of factor XII. Blood 120: 4296-4303.
54. Amer A, Amer ME, (2002) Enhanced monocyte tissue factor expression in hepatosplenic schistosomiasis. Blood Coagul Fibrinolysis 13: 43-47.
55. Tsang VC, Hubbard WJ, Damian RT, (1977) Coagulation factor XIIa (activated hageman factor) inhibitor from adult Schistosoma mansoni. Am J Trop Med Hyg 26: 243-247.
56. Tsang VC, Damian RT, (1977) Demonstration and mode of action of an inhibitor for activated hageman factor (factor XIIa) of the intrinsic blood coagulation pathway from Schistosoma mansoni. Blood 49: 619-633.
57. Foster CB, Flanigan TP, DeStigter KK, Blanton R, Dumenco LL, et al. (1992) Inhibition of the activation of hageman factor (factor XII) by extracts of Schistosoma mansoni. J Lab Clin Med 120: 735-739.
58. Lin YL, He S, (2006) Sm22.6 antigen is an inhibitor to human thrombin. Mol Biochem Parasitol 147: 95-100.
59. Stein LD, David JR, (1986) Cloning of a developmentally regulated tegument antigen of Schistosoma mansoni. Mol Biochem Parasitol 20: 253-264.
60. Renne T, Pozgajova M, Gruner S, Schuh K, Pauer HU, et al. (2005) Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202: 271-281.
61. Beck WS (1985) Hematology. Cambridge: The MIT Press. 496 p.
62. Ghebrehiwet B, Silverberg M, Kaplan AP, (1981) Activation of the classical pathway of complement by hageman factor fragment. J Exp Med 153: 665-676.
63. Robertson NP, Cain GD, (1985) Isolation and characterization of glycosaminoglycans from Schistosoma mansoni. Comp Biochem Physiol B 82: 299-306.
64. Evans DL, McGrogan M, Scott RW, Carrell RW, (1991) Protease specificity and heparin binding and activation of recombinant protease nexin I. J Biol Chem 266: 22307-22312.
65. Blanton RE, Licate LS, Aman RA, (1994) Characterization of a native and recombinant Schistosoma haematobium serine protease inhibitor gene product. Mol Biochem Parasitol 63: 1-11.
66. Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S, (2006) Models of blood coagulation. Blood Cells Mol Dis 36: 108-117.
67. Miles LA, Greengard JS, Griffin JH, (1983) A comparison of the abilities of plasma kallikrein, beta-factor XIIa, factor XIa and urokinase to activate plasminogen. Thromb Res 29: 407-417.
68. Ramajo-Hernandez A, Perez-Sanchez R, Ramajo-Martin V, Oleaga A, (2007) Schistosoma bovis: Plasminogen binding in adults and the identification of plasminogen-binding proteins from the worm tegument. Exp Parasitol 115: 83-91.
69. de la Torre-Escudero E, Manzano-Roman R, Perez-Sanchez R, Siles-Lucas M, Oleaga A, (2010) Cloning and characterization of a plasminogen-binding surface-associated enolase from schistosoma bovis. Vet Parasitol 173: 76-84.
70. de la Torre-Escudero E, Manzano-Roman R, Siles-Lucas M, Perez-Sanchez R, Moyano JC, et al. (2012) Molecular and functional characterization of a Schistosoma bovis annexin: Fibrinolytic and anticoagulant activity. Vet Parasitol 184: 25-36.
71. Skelly PJ, Alan Wilson R, (2006) Making sense of the schistosome surface. Adv Parasitol 63: 185-284.
72. Yang J, Qiu C, Xia Y, Yao L, Fu Z, et al. (2010) Molecular cloning and functional characterization of Schistosoma japonicum enolase which is highly expressed at the schistosomulum stage. Parasitol Res 107: 667-677.
73. Angles-Cano E, (1994) Overview on fibrinolysis: Plasminogen activation pathways on fibrin and cell surfaces. Chem Phys Lipids 67-68: 353-362.
74. Flood EC, Hajjar KA, (2011) The annexin A2 system and vascular homeostasis. Vascul Pharmacol 54: 59-67.
75. Pellegrino J, Coelho PM, (1978) Schistosoma mansoni: Wandering capacity of a worm couple. J Parasitol 64: 181-182.
76. Salafsky B, Fusco AC, (1987) Schistosoma mansoni: A comparison of secreted vs nonsecreted eicosanoids in developing schistosomulae and adults. Exp Parasitol 64: 361-367.
77. Angeli V, Faveeuw C, Roye O, Fontaine J, Teissier E, et al. (2001) Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal langerhans cell migration during schistosomiasis infection. J Exp Med 193: 1135-1147.